PD-L1

PD-L1

Pack Size Cat No
0.2 mL Concentrate MM132-AA
1.0 mL Concentrate MM132-CC
3.0 mL Predilute MM132-3D
6.0 mL Predilute MM132-6D
Categories: ,

Description

The PD-L1 (CD274/B7-H1) is a critical membrane-bound co-stimulatory molecule belongs to the B7 superfamily that inhibits immune responses through its receptor, PD-1 and PD-L1 play a key role in the pathogenesis of inflammatory diseases (programmed death 1). PD-L1 exerts inflammation regulatory functions via a negative co-stimulatory effect on T cell functions to inhibit cytokine secretion, facilitate apoptosis of activated T cells and induce T cell anergy. Abnormal  expression and dysregulation of CD274 have been reported during bacterial infection, inflammation and in numerous autoimmune diseases.PD-L1 is detectable in the malignant nor the nonmalignant cells comprising nodular lymphocyte-predominant Hodgkin lymphoma, DLBCL-not otherwise specified, Burkitt lymphoma, and HHV8-associated Kaposi sarcoma.

Specifications

Alternative Name CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1
Species Mouse
Clone ABM5F25
Isotype Mouse IgG2b Kappa
Dilution Range Assay dependent
Species Reactivity Human
Application IHC
Cell Localization Cytoplasm/Membrane
Positive Control Hodgkin’s Lymphoma

DataSheet & SDS

Download Data Sheet
Download SDS Sheet

References

1. Michael R. Green et al, Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Post-transplant Lymphoproliferative Disorders: Implications for Targeted Therapy , Clinical Cancer Research , January 23, 2012, CCR-11-1942.

2. Benjamin J. Chen et al, PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies ,  CCR-13-0855 , July 2013 .

Request More Information

We would like to get in touch with you for any enquiry related to Pricing/Offer/Product Quotation, Order Support, and Technical Support.

 

Subject *

Name *

Email *

Phone No

Organization

Attach File, if any

Comments